A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in the country that needs it the most, about a-year-and-a-half after US aid cuts hit some of its HIV programmes.

Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa